Brain News and Research

RSS

The human brain is the center of the human nervous system and is a highly complex organ. Enclosed in the cranium, it has the same general structure as the brains of other mammals, but is over three times as large as the brain of a typical mammal with an equivalent body size.

Study: H3 receptor antagonist can improve brain edema in adult hypoxic rats

Thioperamide, a selective histamine H3 receptor antagonist, can increase histamine content in the brain and improve brain edema in adult hypoxic rats. Brain edema is precisely considered as the important pathological change of neonatal hypoxic-ischemic encephalopathy.

13 Aug 2013

Durin receives grant to expand novel blood test that can detect Parkinson's

The Michael J. Fox Foundation for Parkinson's Research has awarded Durin Technologies, Inc., a grant of $351,200 to expand the development of Durin's novel blood test that can detect the presence of Parkinson's disease.

13 Aug 2013

New research opens door for development of treatments capable of stopping Alzheimer's disease

New research just out in the journal Science Translational Medicine opens the door for the development of treatments capable of stopping Alzheimer's disease (AD) before its first symptoms, that is to say before any crucial damage occurs. In fact, if AD is a devastating disorder it is also an extremely slow one; it takes more than 10 years for the first symptoms to appear making this preclinical period (pre-symptoms) the ideal time to intervene.

13 Aug 2013

Flexible hubs coordinate brain’s responses to novel cognitive challenges

One thing that sets humans apart from other animals is our ability to intelligently and rapidly adapt to a wide variety of new challenges - using skills learned in much different contexts to inform and guide the handling of any new task at hand.

13 Aug 2013

Emory’s Yerkes Research Center receives $9.5M grant to establish research center to study oxytocin

The Yerkes National Primate Research Center, Emory University, has received a five-year, $9.5 million grant from the National Institute of Mental Health (NIMH) to establish a Silvio O. Conte Center in Neuroscience Research to study oxytocin, a brain chemical known for forming bonds between mother and baby.

13 Aug 2013

Cedars-Sinai launches Phase I clinical trial to study tolerability of immunization to treat Alzheimer's disease

Cedars-Sinai Medical Center has launched a Phase I clinical trial to study the safety and tolerability of an experimental immunization to treat Alzheimer's disease. The treatment is based on Copaxone (glatiramer acetate), a drug often prescribed to reduce the frequency of multiple sclerosis relapses.

13 Aug 2013

Foreign docs face challenging transition to U.S. system

News outlets report on issues ranging from how foreign doctors are assimilated into the U.S. health care system to how nurse practitioners might help address the physician shortage and the job market nurses are facing.

13 Aug 2013

Simple tests to recognize ability of famous people may help doctors identify early dementia

A new study suggests that simple tests that measure the ability to recognize and name famous people such as Albert Einstein, Bill Gates or Oprah Winfrey may help doctors identify early dementia in those 40 to 65 years of age.

13 Aug 2013

Researchers suggest neural stem cells may regenerate after anti-cancer treatment

Scientists have long believed that healthy brain cells, once damaged by radiation designed to kill brain tumors, cannot regenerate. But new Johns Hopkins research in mice suggests that neural stem cells, the body's source of new brain cells, are resistant to radiation, and can be roused from a hibernation-like state to reproduce and generate new cells able to migrate, replace injured cells and potentially restore lost function.

13 Aug 2013

Study provides clues to improve treatment of neuroblastoma with suppressor gene

Loss of a gene required for stem cells in the brain to turn into neurons may underlie the most severe forms of neuroblastoma, a deadly childhood cancer of the nervous system, according to a Ludwig Cancer Research study.

13 Aug 2013

Researchers explore potential of neural stem cells to repair brain damage

Scientists have long believed that healthy brain cells, once damaged by radiation designed to kill brain tumors, cannot regenerate. But new Johns Hopkins research in mice suggests that neural stem cells, the body’s source of new brain cells, are resistant to radiation, and can be roused from a hibernation-like state to reproduce and generate new cells able to migrate, replace injured cells and potentially restore lost function.

13 Aug 2013

First Edition: Aug. 12, 2013

Today's headlines include reports about state action on the health law's implementation and other news from the health insurance marketplace.

12 Aug 2013

Researchers develop algorithms to improve procedures in cardiac resuscitation

An algorithm capable of diagnosing heart rhythm with just 3 seconds' worth of signal, and the demonstration that it is possible to come up with the diagnosis without stopping cardiac massage, constitute the types of solutions and proposals being developed by researchers in the Signal and Communications Group of the Faculty of Engineering in Bilbao (UPV/EHU-University of the Basque Country).

12 Aug 2013

Researchers identify first disease gene for idiopathic focal epilepsy in childhood

More than 50 million people worldwide have epilepsy, with a third of these being children. The most common forms of epilepsy in children occur without any apparent trigger and only affect certain regions of the brain.

12 Aug 2013

Omeros announces financial results for second quarter of 2013

Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2013.

12 Aug 2013

NW Bio receives decision to continue Phase III clinical trial on brain cancer in Germany

Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.

12 Aug 2013

Brain News and Research

Further Reading

Study: H3 receptor antagonist can improve brain edema in adult hypoxic rats

Durin receives grant to expand novel blood test that can detect Parkinson's

New research opens door for development of treatments capable of stopping Alzheimer's disease

Flexible hubs coordinate brain’s responses to novel cognitive challenges

Emory’s Yerkes Research Center receives $9.5M grant to establish research center to study oxytocin

Cedars-Sinai launches Phase I clinical trial to study tolerability of immunization to treat Alzheimer's disease

Foreign docs face challenging transition to U.S. system

Simple tests to recognize ability of famous people may help doctors identify early dementia

Researchers suggest neural stem cells may regenerate after anti-cancer treatment

Study provides clues to improve treatment of neuroblastoma with suppressor gene

Researchers explore potential of neural stem cells to repair brain damage

First Edition: Aug. 12, 2013

Researchers develop algorithms to improve procedures in cardiac resuscitation

Researchers identify first disease gene for idiopathic focal epilepsy in childhood

Omeros announces financial results for second quarter of 2013

NW Bio receives decision to continue Phase III clinical trial on brain cancer in Germany

Dopamine responses to alcohol ingestion may serve as marker of vulnerability to AUDs

Shape and meaning: A study explores how brain encodes visual objects

Congress weighing changes to Medicare reimbursements for doctors

Study reveals gray matter atrophy in multiple sclerosis correlated with emotional decline

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News